Acquisition of Reagents for Lyme Disease Serodiagnosis

The Institut national de santé publique du Québec (INSPQ) is seeking to acquire reagents essential for the serodiagnostic testing of Lyme disease. This procurement falls under the category of Chemicals and Chemical Products (G4), specifically chemical, biochemical, and gaseous products. The procurement method is a direct award contract (Contrat de gré à gré), justified under Article 13, Paragraph 4°, which allows for direct negotiation when a public tender would not serve the public interest. This rationale suggests that there may be specific reasons, such as the need for specialized or proprietary reagents, urgent requirements, or limited supplier availability, that make a competitive bidding process impractical or detrimental to public health objectives. The INSPQ plays a crucial role in public health surveillance and diagnostics in Quebec, and ensuring a consistent supply of high-quality reagents for Lyme disease testing is vital for accurate diagnosis, disease monitoring, and public health response. This acquisition will support the laboratory's capacity to perform these critical diagnostic tests, contributing to the management and understanding of Lyme disease within the province.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Laboratory and General Supplies. Located in Canada, North America, this opportunity is open to firms and consortiums.

Published through Quebec SEAO, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.